Non-Alcholic Fatty Liver
Article Sidebar
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Main Article Content
Abstract
Background: Despite this heterogeneity, young adults are generally thought to be at a decreased risk of developing metabolic liver disorders. The clinical features, severity, biochemical profiles, and related metabolic variables of non-alcoholic fatty liver disease (NAFLD) in IMF medical students between the ages of 18 and 35 are examined in this study.
Article Details
References
American Association for the Study of Liver Diseases (AASLD) Practice Guidance (2023) This guideline provides comprehensive recommendations for the clinical assessment and management of NAFLD, including diagnostic strategies and treatment options. PubMed
Nonalcoholic fatty liver disease - Diagnosis and treatment - Mayo Clinic
Younossi ZM, et al. "Understanding the Burden of Nonalcoholic Fatty Liver Disease" (2024) This study discusses the prevalence and impact of NAFLD, highlighting its increasing burden globally. PMC
"Therapies for Non-Alcoholic Fatty Liver Disease: A 2022 Update" by Shen K, et al. This article reviews the latest therapeutic approaches for managing NAFLD, including lifestyle interventions and pharmacological treatments. PMC